UNSPSC 51371910: Methadone hydrochloride

This classification denotes a synthetic opioid, opiate substitution treatment, analgesics, and antitussive agent with the molecular formula C21H27NO.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 229809935B, chemically known as 6-dimethylamino-4,4-diphenyl-heptan-3-one but more generally known as methadone hydrochloride, which bears US NIH Compound Identifier 4095. European Medicines Agency schedules Methadone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03203MIG.

UNSPSC 51371910 Methadone hydrochloride is a Commodity code that in practice sees minimal recent state and local procurement activity aligned with its nominal scope. The single recent opportunity in the available records — Seminole County, Florida's IFB 60459723LAS — is tagged to this code but solicits Naloxone and drug deactivation systems, not methadone. State and local health departments and county public health agencies appear to be the primary issuing bodies when procurement under this code does occur, though the sparse activity record limits conclusions about buyer concentration or repeat procurement patterns.

Seminole County, Florida posted the only recent relevant opportunity on June 30, 2026 with a response deadline of July 26, 2023, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The IFB specifies a two-year initial term with one-year renewal option, electronic bid submission through the county's e-Procurement Portal, all-inclusive delivery pricing, E-Verify compliance, drug-free workplace certification, and compliance with FEMA requirements including the Clean Air Act and Federal Water Pollution Control Act. The code shows no meaningful current activity outside Florida and does not support a characterization of active geographic spread.